{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:44:22Z","timestamp":1791852262096,"version":"4.3.4"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12374413"],"award-info":[{"award-number":["12374413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Invasive papillary carcinoma is a rare form of breast cancer that is more likely to occur in postmenopausal women. Previous studies have been limited to case reports and small retrospective studies, leading to low awareness of this type of tumor and difficult clinical management. According to the available literature, invasive papillary carcinoma exhibits unique pathological features and biological behaviors. Invasive papillary carcinoma is mostly luminal type, with a low rate of lymph node metastasis, which underlies its favorable prognosis. The effectiveness of adjuvant therapy in reducing tumor burden and improving prognosis in patients with invasive papillary carcinoma remains uncertain. Due to the rarity of the lesion, conducting prospective clinical trials is impractical. The use of biological models, such as organoids, can help alleviate the impact of the scarcity of this condition on research. In addition, invasive papillary carcinoma is affected by specific genomic events, and more extensive studies of gene expression profiling may provide molecular-level insights to make optimal therapeutic decisions.<\/jats:p>","DOI":"10.3389\/fonc.2024.1374091","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:57:41Z","timestamp":1711515461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Invasive papillary carcinoma of the breast"],"prefix":"10.3389","volume":"14","author":[{"given":"Shijing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0219-RA","article-title":"Papillary lesions of the breast: A practical approach to diagnosis","volume":"140","author":"Jorns","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4132\/jptm.2021.07.29","article-title":"A multicenter study of interobserver variability in pathologic diagnosis of papillary breast lesions on core needle biopsy with WHO classification","volume":"55","author":"Kang","year":"2021","journal-title":"J Pathol Transl Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5427837","article-title":"Papillary carcinoma of breast: clinicopathological characteristics, management, and survival","volume":"2022","author":"Rehman","year":"2022","journal-title":"Int J Breast Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02626-5","article-title":"Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with Malignancy on surgical excision","volume":"475","author":"MacColl","year":"2019","journal-title":"Virchows Arch"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.3483","article-title":"Spectrum of papillary lesions of the breast: clinical, imaging, and pathologic correlation","volume":"191","author":"Muttarak","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7922","article-title":"Papillary lesions of the breast: MRI, ultrasound, and mammographic appearances","volume":"198","author":"Eiada","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0961-5","article-title":"Papillary carcinoma of the breast: an overview","volume":"122","author":"Pal","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"B8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.amjsurg.2007.06.016","article-title":"Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy","volume":"194","author":"Fayanju","year":"2007","journal-title":"Am J Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13050878","article-title":"Clinicopathological and imaging features of breast papillary lesions and their association with pathologic nipple discharge","volume":"13","author":"Oh","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e11026","DOI":"10.7759\/cureus.11026","article-title":"Spectrum of papillary breast lesions according to world health organization classification of papillary neoplasms of breast","volume":"12","author":"Hashmi","year":"2020","journal-title":"Cureus"},{"key":"B11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3760\/cma.j.issn.0529-5807.2013.02.002","article-title":"[The introduction of 2012 WHO classification of tumours of the breast]","volume":"42","author":"Yang","year":"2013","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"B13","article-title":"[Invasive papillary and pseudopapillary (micropapillary) carcinoma of breast]","volume":"44","author":"Gentile","year":"1996","journal-title":"Arch Anat Cytol Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/73.3.313","article-title":"Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancer","volume":"73","author":"Fisher","year":"1980","journal-title":"Am J Clin Pathol"},{"key":"B15","article-title":"Trend analyses of breast cancer incidence and mortality in Vojvodina","volume":"25","author":"Dugandzija","year":"2020","journal-title":"J BUON"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21916","article-title":"Cytomorphologic features of papillary lesions of the male breast: a study of 11 cases","volume":"108","author":"Reid-Nicholson","year":"2006","journal-title":"Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/PAS.0000000000001340","article-title":"Papillary lesions of the male breast: A study of 117 cases and brief review of the literature demonstrate a broad clinicopathologic spectrum","volume":"44","author":"Zhong","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00432-012-1302-3","article-title":"Clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast: a large case study","volume":"139","author":"Liu","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"B19","article-title":"Papillary carcinoma of the breast. A cytomorphologic analysis","volume":"110","author":"Kline","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4274\/ejbh.galenos.2022.2022-7-4","article-title":"The clinicopathologic features of 22 cases with primary invasive papillary carcinoma of the breast identified in 1153 cases with invasive breast carcinoma: single-center experience","volume":"18","author":"Kelten Talu","year":"2022","journal-title":"Eur J Breast Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02404.x","article-title":"Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens","volume":"48","author":"Shah","year":"2006","journal-title":"Histopathology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5858\/2005-129-1465-EDIBLA","article-title":"Epithelial displacement in breast lesions: a papillary phenomenon","volume":"129","author":"Nagi","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.1128.13.7","article-title":"Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma","volume":"13","author":"Anderson","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000321270","article-title":"Invasive papillary breast carcinoma","volume":"3","author":"Bhosale","year":"2010","journal-title":"Case Rep Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13480","article-title":"Invasive papillary carcinoma of the breast: clinicopathological features and hormone receptor profile","volume":"13","author":"Hashmi","year":"2021","journal-title":"Cureus"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep24037","article-title":"Clinicopathological characteristics and survival outcomes in invasive papillary carcinoma of the breast: A SEER population-based study","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2009.12.004","article-title":"and papillary carcinoma","volume":"27","author":"Papilloma","year":"2010","journal-title":"Semin Diagn Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-006-0305-3","article-title":"Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 cases","volume":"449","author":"Burga","year":"2006","journal-title":"Virchows Arch"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the national cancer database for outcomes research: A review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2020.12.026","article-title":"Clinicopathologic characteristics and prognosis of invasive papillary carcinoma of the breast","volume":"261","author":"Huang","year":"2021","journal-title":"J Surg Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.171.2.2649917","article-title":"Invasive papillary breast carcinoma: mammographic and sonographic appearance","volume":"171","author":"Schneider","year":"1989","journal-title":"Radiology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2008.02.012","article-title":"Radiological appearances of papillary breast lesions","volume":"63","author":"Brookes","year":"2008","journal-title":"Clin Radiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2014.06.018","article-title":"Clinical and imaging characteristics of papillary neoplasms of the breast associated with Malignancy: a retrospective cohort study","volume":"40","author":"Choi","year":"2014","journal-title":"Ultrasound Med Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.177.3.2243993","article-title":"Invasive papillary carcinoma of the breast: mammographic appearance","volume":"177","author":"Mitnick","year":"1990","journal-title":"Radiology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.5114\/wo.2023.124755","article-title":"Comparison of ultrasonographic and mammographic features of extremely rare papillary carcinoma and invasive ductal carcinoma","volume":"26","author":"Balsak","year":"2022","journal-title":"Contemp Oncol (Pozn)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2023.02.010","article-title":"Differential diagnosis of benign and Malignant breast papillary neoplasms on MRI with non-mass enhancement","author":"Zhou","year":"2023","journal-title":"Acad Radiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13244-021-01005-6","article-title":"High-risk lesions of the breast: concurrent diagnostic tools and management recommendations","volume":"12","author":"Catanzariti","year":"2021","journal-title":"Insights Imaging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2017.10.005","article-title":"Diagnostic challenges in papillary lesions of the breast","volume":"50","author":"Rakha","year":"2018","journal-title":"Pathology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.231038","article-title":"Encapsulated papillary carcinoma of the breast","volume":"308","author":"Bai","year":"2023","journal-title":"Radiology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00732-3","article-title":"Papillary neoplasms of the breast-reviewing the spectrum","volume":"34","author":"Tay","year":"2021","journal-title":"Mod Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41379-020-00706-5","article-title":"Papillary neoplasms of the breast including upgrade rates and management of intraductal papilloma without atypia diagnosed at core needle biopsy","volume":"34","author":"Brogi","year":"2021","journal-title":"Mod Pathol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00428-021-03182-7","article-title":"Papillary lesions of the breast","volume":"480","author":"Kulka","year":"2022","journal-title":"Virchows Arch"},{"key":"B43","article-title":"Invasive papillary carcinoma of the mammary gland: histopathologic and immunohistochemical aspects","volume":"53","author":"Eremia","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2011-0227-RS","article-title":"Solid papillary carcinoma of the breast: a pathologically and clinically distinct breast tumor","volume":"136","author":"Saremian","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092376","article-title":"Tall cell carcinoma with reversed polarity: case report of a rare special type of breast cancer and review of the literature","volume":"11","author":"Elghobashy","year":"2023","journal-title":"Biomedicines"},{"key":"B46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/00000478-199806000-00006","article-title":"Mucinous cystadenocarcinoma of the breast","volume":"22","author":"Koenig","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950101)75:1+<257::aid-cncr2820751311>3.0.co;2-y","article-title":"Breast cancer","volume":"75","author":"Berg","year":"1995","journal-title":"Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0133-RA","article-title":"Immunohistochemical surrogates for molecular classification of breast carcinoma: A 2015 update","volume":"140","author":"Tang","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.12.006","article-title":"Lung cancer","volume":"103","author":"Nasim","year":"2019","journal-title":"Med Clin North Am"},{"key":"B50","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880399","article-title":"Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma","volume":"14","author":"Nassar","year":"2001","journal-title":"Mod Pathol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/his.12861","article-title":"Breast lesions of uncertain Malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management","volume":"68","author":"Rakha","year":"2016","journal-title":"Histopathology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0012-1606(02)00048-9","article-title":"Disruption of sonic hedgehog signaling alters growth and patterning of lingual taste papillae","volume":"255","author":"Hall","year":"2003","journal-title":"Dev Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117200","article-title":"Hepatocyte growth factor\/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium","volume":"93","author":"Nusrat","year":"1994","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.127.6.1783","article-title":"Scatter factor and the c-met receptor: a paradigm for mesenchymal\/epithelial interaction","volume":"127","author":"Rosen","year":"1994","journal-title":"J Cell Biol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/his.12866","article-title":"Pathological criteria and practical issues in papillary lesions of the breast - a review","volume":"68","author":"Ni","year":"2016","journal-title":"Histopathology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-3003-3","article-title":"Papillary lesions of the breast: a molecular progression","volume":"90","author":"Di Cristofano","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J Pathol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Troxell","year":"2010","journal-title":"Mod Pathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64269-1","article-title":"Pathway pathology: histological differences between ErbB\/Ras and Wnt pathway transgenic mammary tumors","volume":"161","author":"Rosner","year":"2002","journal-title":"Am J Pathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/path.2599","article-title":"Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation","volume":"219","author":"McCarthy","year":"2009","journal-title":"J Pathol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities","volume":"19","author":"Xu","year":"2020","journal-title":"Mol Cancer"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203191","article-title":"Morphogenesis of the papillary lesions of the breast: phenotypic observation","volume":"69","author":"Rakha","year":"2016","journal-title":"J Clin Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31821b3f65","article-title":"Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis","volume":"35","author":"Rakha","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2007.02898.x","article-title":"Papillary lesions of the breast: selected diagnostic and management issues: Papillary breast lesions","volume":"52","author":"Collins","year":"2007","journal-title":"Histopathology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5465261","article-title":"Solid pseudopapillary neoplasm of the pancreas: clinicopathologic feature, risk factors of Malignancy, and survival analysis of 53 cases from a single center","volume":"2017","author":"Song","year":"2017","journal-title":"BioMed Res Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196205\/06)15:3<444::aid-cncr2820150303>3.0.co;2-0","article-title":"The differential diagnosis of papillary tumors of the breast","volume":"15","author":"Kraus","year":"1962","journal-title":"Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2014-202331","article-title":"Cell cycle marker expression in benign and Malignant intraductal papillary lesions of the breast","volume":"68","author":"Loh","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22412","article-title":"Papillary lesions of the breast: A systematic evaluation of cytologic parameters","volume":"129","author":"Jamidi","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/his.12463","article-title":"Papillary and neuroendocrine breast lesions: the WHO stance","volume":"66","author":"Tan","year":"2015","journal-title":"Histopathology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030946","article-title":"Nontoxic fluorescent nanoprobes for multiplexed detection and 3D imaging of tumor markers in breast cancer","volume":"15","author":"Sokolov","year":"2023","journal-title":"Pharmaceutics"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/his.14799","article-title":"Pitfalls in breast pathology","volume":"82","author":"Quinn","year":"2023","journal-title":"Histopathology"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-023-01295-y","article-title":"Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival","volume":"18","author":"Helal","year":"2023","journal-title":"Diagn Pathol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1186\/s12885-022-09567-4","article-title":"BARD1 mystery: tumor suppressors are cancer susceptibility genes","volume":"22","author":"Hawsawi","year":"2022","journal-title":"BMC Cancer"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3725391","article-title":"Natural history of invasive papillary breast carcinoma followed for 10 years: A case report and literature review","volume":"2017","author":"Suh","year":"2017","journal-title":"Case Rep Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1038\/s41467-018-07406-4","article-title":"High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer","volume":"9","author":"Echeverria","year":"2018","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting metastatic cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-021-10090-2","article-title":"Mechanisms of breast cancer metastasis","volume":"39","author":"Nathanson","year":"2022","journal-title":"Clin Exp metastasis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/path.2743","article-title":"Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas","volume":"222","author":"Lopez-Garcia","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20646","article-title":"Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype","volume":"48","author":"Natrajan","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1878","article-title":"Tiling path genomic profiling of grade 3 invasive ductal breast cancers","volume":"15","author":"Natrajan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1173","article-title":"Phosphoinositide 3-kinase mutations in breast cancer: a \u201cgood\u201d activating mutation","volume":"15","author":"Di Cosimo","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/path.2648","article-title":"The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade","volume":"220","author":"Weigelt","year":"2010","journal-title":"J Pathol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.06.011","article-title":"Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast","volume":"8","author":"Piscuoglio","year":"2014","journal-title":"Mol Oncol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr3407","article-title":"Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer","volume":"15","author":"Katchman","year":"2013","journal-title":"Breast Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01171-5","article-title":"Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model","volume":"20","author":"Li","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B90","doi-asserted-by":"publisher","first-page":"OF4","DOI":"10.1158\/2159-8290.CD-NB2016-047","article-title":"MammaPrint reduces breast cancer overtreatment","volume":"6","year":"2016","journal-title":"Cancer Discovery"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12358","article-title":"Breast cancer: an up-to-date review and future perspectives","volume":"42","author":"Hong","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: A review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"B93","doi-asserted-by":"publisher","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"B94","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrclinonc.2013.124","article-title":"Luminal breast cancer: from biology to treatment","volume":"10","author":"Ignatiadis","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13104-016-1854-4","article-title":"Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved","volume":"9","author":"Saita","year":"2016","journal-title":"BMC Res Notes"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1307118","article-title":"Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer","volume":"383","author":"Burstein","year":"2020","journal-title":"N Engl J Med"},{"key":"B97","first-page":"1991","article-title":"Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database","volume":"26","author":"Chen","year":"2021","journal-title":"J BUON"},{"key":"B98","article-title":"Histological typing of breast tumors","volume":"30","year":"1983","journal-title":"Neoplasma"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1374091\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:58:46Z","timestamp":1711515526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1374091\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":98,"alternative-id":["10.3389\/fonc.2024.1374091"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1374091","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"article-number":"1374091"}}